What is an IRB (Institutional Review Board)?
|
|
- Lorin Maxwell
- 6 years ago
- Views:
Transcription
1 What is an IRB (Institutional Review Board)?
2 The Belmont Report The Belmont Report on the Ethical Principles and Guidelines for the Protection of Human Subjects of Research was prepared by the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research in 1979.
3 The Belmont Report Three ethical principles are outlined in the Belmont Report: Respect for Persons = voluntary informed consent Acknowledges the subject s s autonomy Those with diminished capacity are entitled to extra protections Children Pregnant women and fetuses Prisoners Subjects with diminished cognitive capacity Temporary (trauma, drug or alcohol related) Permanent (Neurodegenerative disorders Alzheimer s) Non-English speaking subjects Illiterate Surrogate consent
4 The Belmont Report Beneficence = Do no harm, maximize benefits and minimize harm Risk/Benefit ratio This is very difficult to establish. Often new interventions have a relatively limited history of use and therefore many potential risks and the level of benefit are unknown. Requires a constant reassessment of the study in light of evolving efficacy and safety data IRBs Data Safety Monitoring Boards Investigators FDA
5 The Belmont Report Justice = Equitable distributions of the burdens and benefits of research. Is the study sufficiently representative of the society as a whole? Diverse representation is a goal of the NIH and FDA Improves the generalizability of findings Distributes potential benefits Shares potential risks
6 Federal Policy and Regulations Used the Belmont Report as a framework The Common Rule is a federal policy regarding Human Subjects Protection that applies to 17 Federal agencies and offices. It does not apply to federal agencies that have not signed the agreement (e.g., Department of Labor), however most agencies that are involved in human subject research are bound by the common rule. The main elements of the Common Rule include: Requirements for assuring compliance by research institutions Federal Wide Assurance
7 Federal Policy and Regulations Requirements for researchers to obtain and document voluntary informed consent Requirements for Institutional Review Boards (IRBs) Membership Function Operations Review of research Record keeping
8 Federal Policy and Regulations The Common Rule includes additional protections for certain vulnerable research subjects. Subpart B provides additional protections for pregnant women, in vitro fertilization, and fetuses Subpart C contains additional protections for prisoners Subpart D contains additional protections for children
9 Federal Policy and Regulations Agency Regulations DHHS Regulations are detailed in 45 CFR, Part _99.html FDA Regulations are detailed in 21 CFR, Part 50, and 21 CFR, Part bin/cfrassemble.cgi?title=199945
10 Federal Policy and Regulations The common rule only applies to research for FDA approval process and federally funded research, however: DHHS Federal Wide Assurance (FWA) An institution with a DHHS approved Federal Wide Assurance typically agrees to apply DHHS regulations to all research regardless of the funding source (checking the box) includes research that is internally initiated and funded international research collaborative research across institutions.
11 Federal Policy and Regulations FDA Regulations FDA regulations apply to clinical investigators and regulates products, drugs, devices, food and color additives. FDA generally regulates, but does not support or conduct research. FDA regulations for informed consent are codified in 21 CFR, Part 50. Note: There are subtle or not so subtle differences between DHHS and FDA regulations particularly with regards to investigational devices and conflicts of interest.
12 What are the responsibilities of the researcher, sponsor, subject and IRB? All four are responsible for insuring subject safety IRB evaluates the study for: Scientific soundness Consent readability and completeness of disclosure Monitors adverse events (side effects) both individually at the local level (internal adverse events) and through monitoring of MedWatch reports, CTSU action letters, FDA drug updates and DSMB reports etc. Insures or attempts to insure the following parties are monitoring safety
13 What are the responsibilities of the researcher, sponsor, subject and IRB? Researcher Insures the subject understands the proposed study and risks (truly informed consent) Monitors subjects on an individual and aggregate basis for emerging safety issues Keeps the subject informed about changes related to safety, efficacy and other findings that occur during the study (participants may withdraw from a study without prejudice at any time) Insures that any conflicts of interest are disclosed and meet federal guidelines. If they exist they are managed appropriately
14 What are the responsibilities of the researcher, sponsor, subject and IRB? Sponsor Discloses all relevant information relating to the study Previous human trials Phase 1 Phase 2 Phase 3 In vitro studies (i.e. cell cultures) Animal trials if any Pharmacologic studies Monitors the trial on an ongoing basis through Data Safety Monitoring Board (DSMB) or other alternative monitor Subject Yes that s s right subjects are an active participants Should know what side effects might occur Report any potential side effects promptly to the researcher Ask lots of questions to insure understanding
15 So what is an IRB? Institutional Review Board (Ethics Review Boards in other countries) A quasi-regulatory body Originally designed to address research design and ethics within specific institutions Not originally designed with a regulatory function in mind Co-opted opted by the government to fulfill the regulatory function of the Common Rule (45 CFR: 46, 21 CFR:20 and 26)
16 So what is an IRB? Research protection is only one of the functions of the IRB Addresses issues of research design (A well designed study to answer a question that is not worth asking is not worth doing). Not having a Joe Biden moment here, I just can t t remember where I heard this, but it s s not my brilliant revelation Risk/benefit analysis. What is Minimal Risk? Minimal risk is a term that is critical to the way IRBs evaluate proposed research means the risks of harm anticipated in the proposed research are not greater, considering both probability and magnitude, than those ordinarily encountered in daily life, or during routine physical examinations What does this concept mean to a critically ill cancer patient? As you might imagine this is one of the more difficult concepts to apply
17 So what is an IRB? Asks the question is this really human subject research? This is the most important question to ask if the answer is yes common rule applies, if no the common rule does not and the IRB does not have jurisdiction What is research? Research means: A A systematic investigation designed to develop or contribute to generalized knowledge It It includes research, development, testing, evaluation and pilot studies
18 So what is an IRB? What is a human subject? Also very important Human Subject means: a living human individual about whom an investigator conducting research obtains data through intervention or interaction with the individual identifiable private information (health data and demographic data)
19 So what is an IRB? Often the IRB acts as the Privacy Board for Health Insurance Portability and Accountability Act (HIPAA) related issues Since human research may and often does involve disclosure of protected health information, the IRB provided a convenient way to insure the disclosure to the subject of what information is being collected, by whom, for what purpose, who will be looking at the information and what the subjects rights are regarding use of their information.
20 So What is an IRB? Informed Consent Required elements of the Informed Consent from the Common Rule A statement that the study involves research, an explanation of the purposes of the research and the expected duration of the subject's participation, a description of the procedures to be followed, and identification of any procedures which are experimental. A description of any reasonably foreseeable risks or discomforts to the subject. Discloses that unexpected and unknown side effects may emerge (adverse events include not only physical effects, but also adverse social, financial and psychological effects)
21 So What is an IRB? A description of any benefits to the subject or to others which may reasonably be expected from the research. This is difficult to address for the individual and is often poorly fleshed out in consent forms. A disclosure of appropriate alternative procedures or courses of treatment, if any, that might be advantageous to the subject. A statement describing the extent, if any, to which confidentiality of records identifying the subject will be maintained and that notes the possibility that the Food and Drug Administration and other regulatory bodies and industry sponsors may inspect the records.
22 So What is an IRB? For research involving more than minimal risk (almost all research), an explanation as to whether there is any compensation and an explanation as to whether any medical treatments are available if injury occurs and, if so, what they consist of, or where further information may be obtained. An explanation of whom to contact for answers to questions about the research and research subjects' rights, and whom to contact in the event of a research-related related injury. Make sure that the local IRB is listed
23 So What is an IRB? A statement that participation is voluntary, that refusal to participate will involve no penalty or loss of benefits to which the subject is otherwise entitled, and that the subject may discontinue participation at any time without penalty or loss of benefits to which the subject is otherwise entitled. A statement that by signing the consent the subject does not waive any legal rights.
24 So What is an IRB? Optional but usual elements of the Informed Consent A statement that the particular intervention or procedure may involve risks to the subject or to the embryo or fetus, if the subject is or may become pregnant which are currently unforeseeable. Anticipated circumstances under which the subject's participation may be terminated by the investigator without regard to the subject's consent or wishes. Any additional costs to the subject that may result from participation in the research and the consent is free of exculpatory language.
25 So What is an IRB? The consequences of a subjects' decision to withdraw from the research and the procedures for orderly termination of participation by the subject. Intended to protect the participant A statement that significant new findings developed during the course of the research which may relate to the subject s s willingness to continue participation will be provided to the subject. This is an important point! The approximate number of subjects involved in the study.
26 So What is an IRB? The Informed Consent Process Informed consent is more than just a signature on a form.
27 Conflicts of Interest Recent research scandals brought to light the corrupting influence conflicts of interest can have on research Jesse Gelsinger The NIH and FDA have rules regarding what constitutes a conflict of interest that emphasize financial conflicts of interest However, COIs can take many forms other than financial conflicts Reputation Power Tenure Blind enthusiasm Etc.
28 Conflicts of Interest IRBs must insure that at a minimum the federal requirements relating to conflict of interest are addressed Further IRB members should be free of interests in the studies in question or recuse themselves from deciding the disposition of a study that they are directly involved
29 Composition of the IRB No set number of members Required composition Scientific members Lay members (Community members, nonscientific) Unaffiliated members Quorum At least one scientific member At least one community member (nonscientific) Over 50% of the board must be present for any vote Members with conflicts of interest may not participate in the vote Recuss Physically leave the room Additional members or consultants with specialized knowledge are retained as appropriate (i.e. pediatrics, criminal justice, women s s issues, community/cultural issues)
30 Role of the IRB chair Do not impose a personal agenda Facilitate discussion Minimize unnecessary delays Engage all members in the discussion Provide scientific leadership
31 Role of the scientific members Evaluate the scientific rationale Evaluate the study for potential risks Evaluate the study for potential benefit Risk/Benefit ratio
32 Role of community members Evaluate the understandability of the consent Ask any and all questions Evaluate the risks vs. expected benefit Evaluate the study from the standpoint of community standards (ex. Research conducted in a Native American Community, research involving vulnerable populations etc.) Community members are often research activists, former subjects, family members of former subjects, lawyers, clergy, business people Community members play a key role in IRB deliberations
33 Special Consultants When an IRB evaluates a study in a field where the members have limited or no expertise it is expected that the IRB will engage an expert in the field who advises but usually does not vote on the study and who has no conflicts of interest Vulnerable populations Prisoners Children Pregnant women Others Note: The IH-DM IRB #1 considers pediatric studies and therefore must have members who are experienced in pediatric research and care
34 Required reviews Initial review Exempt Expedited Full board review Continuing reviews At least yearly May be more frequent depending on the risk level Should be as rigorous as the initial review Special attention should be paid to new information relating to the study and safety reviews
35 Required reviews Amendments, revisions and addenda All changes to studies must be reviewed and approved by the IRB If the change represents a change in the risk profile recruitment is suspended and current participants must be notified in a prompt fashion. Recruitment can only continue after IRB approval (OHRP and CTSU), although at times the approval may be expedited
36 The power of the IRB An IRB can demand substantive changes to a protocol. Vote down a protocol. Table a protocol if there are substantive issues to be resolved. The IRB is expected to report suspected misconduct or other unanticipated problems that emerge during the course of a study to FDA, OHRP and others. Iowa Health may not approve a study over the objection of the IHDM - IRBs
37 Questions and further guidance IRBs #1 and # Jane Spencer IRB #1 chair Dr. Drevyanko IRB #2 chair Dr. Drevyanko
Ethical Principles in Clinical Research
Ethical Principles in Clinical Research Christine Grady NIH Clinical Center Department of Bioethics No conflicts of interest. Views presented are mine and do not necessarily represent positions or policies
More informationTop Ten Investigator Responsibilities When Conducting Human Subjects Research
Top Ten Investigator Responsibilities When Conducting Human Subjects Research Thanks to Ada Sue Selwitz, Univ. of Kentucky and PRIM&R (Public Responsibility in Medicine & Research) Investigator Responsibility
More informationTOP 10 INVESTIGATOR RESPONSIBILITIES WHEN CONDUCTING HUMAN SUBJECTS RESEARCH
Investigators Responsibility #1: Design and Implement Ethical Research Consistent with the Three Ethical Principles Delineated in The Belmont Report. The Belmont Report: Three Basic Ethical Principles:
More informationRules of Human Experimentation
Rules of Human Experimentation Elaine Larson CUMC IRB Chair Associate Dean for Research, School of Nursing Professor of Epidemiology, Mailman School of Public Health Oversight for Human Research Office
More informationEthical Principles in Clinical Research. Disclaimer. Christine Grady Department of Bioethics NIH Clinical Center
Ethical Principles in Clinical Research Christine Grady Department of Bioethics NIH Clinical Center Disclaimer The views expressed are mine and do not necessarily represent the positions or policies of
More informationEIGHT BASIC ELEMENTS OF INFORMED CONSENT
1/6 This guidance addresses: o Eight Basic elements of informed consent o Additional elements of informed consent o Other information required by the IRB EIGHT BASIC ELEMENTS OF INFORMED CONSENT Required
More informationS A I N T M A RY S E M I N A RY O C T O B E R 1 9,
IRB BASICS FOR ADMINISTRATORS S A I N T M A RY S E M I N A RY O C T O B E R 1 9, 2 0 1 6 JOHN CARROLL UNIVERSITY Catherine Anson, MA, CRA, CIM Director of Sponsored Research Assistant IRB Chair Carole
More informationHuman Subjects Protection: Training for Research Teams
Human Subjects Protection: Training for Research Teams Walter L. Calmbach MD MPH South Texas Ambulatory Research Network (STARNet) Dept. of Family & Community Medicine Univ. of Texas Health Science Center
More informationProtection of Research Participants: The IRB Process and the Winds of Change
Protection of Research Participants: The IRB Process and the Winds of Change Ethics in Patient-Oriented Research October 12, 2011 Sharon Friend Director, OHRPP Overview Charge and Function of the IRB Quick
More informationResearch: Ethics, Informed Consent, FDA, Off Label Use
Research: Ethics, Informed Consent, FDA, Off Label Use Nasim Hedayati, MD, FACS, RPVI Assistant Professor Division of Vascular and Endovascular Surgery University of California, Davis 2015 Phlebology Review
More informationAnnual Research Administrators Symposium IRB Compliance. Thursday, July 31, 2014
Annual Research Administrators Symposium IRB Compliance Thursday, July 31, 2014 Why IRB Compliance Is Required for Grant Submissions Topics to Cover Today What is an IRB? Why IRB review is required? Regulatory
More informationAdvocate Health Care Network. Human Research Protection Program. Plan
Advocate Health Care Network Human Research Protection Program Plan Revised October 19, 2014 Page 1 Table of Contents Scope... 3 Purpose... 3 Definitions... 3 Clinical Trial... 3 Engaged in Human Research...
More informationHuman Subjects Protection Program Plan
December 1, 2016 HRP-101 12/1/16 2 of 12 Table of Contents Scope... 3 Purpose... 3 Definitions... 3 Agent... 3 Clinical Trial... 3 Engaged in Human Research... 3 Human Research:... 4 Human Subject as Defined
More informationTrends in Oversight of Human Research Protections?
Trends in Oversight of Human Research Protections? Greg Koski, PhD, MD Associate Professor, Harvard Medical School Senior Scientist, James Mongan Institute for Health Policy Former Director, Office for
More informationWCG ACADEMY COURSE OVERVIEW
WCG ACADEMY COURSE OVERVIEW Investigator Course Title Documentation of Informed Consent Duration Ethical Principles Underlying Consent Documentation Long Form Short Form Consent Records Special Considerations
More informationHuman Research Protection Program Plan
Revised January 19, 2018 Table of Contents Human Research Protection Program Plan HRP-101 1/19/2018 2 of 13 Scope... 3 Purpose... 3 Definitions... 3 Agent... 3 Clinical Trial... 3 Engaged in Human Research...
More informationThe Role of the IRB in Clinical Trials: What Patients and Families Need to Know. Marjorie A. Speers, Ph.D. Executive Director, WCG Foundation
The Role of the IRB in Clinical Trials: What Patients and Families Need to Know Marjorie A. Speers, Ph.D. Executive Director, WCG Foundation 1 CAC2 Values v Put the children and their families first in
More informationEthical Oversight of Human Subject Research. Susan Burner Bankowski, MS,JD OHSU IRB Chair Director, Research Ethics Program
Ethical Oversight of Human Subject Research Susan Burner Bankowski, MS,JD OHSU IRB Chair Director, Research Ethics Program Mandate of the IRB Review all research involving human subjects performed by OHSU
More informationNorthwestern University HSPP Policy Manual Page 2 of 116
Northwestern University HSPP Policy Manual Page 2 of 116 POLICY FOR HUMAN SUBJECTS RESEARCH AT NORTHWESTERN UNIVERSITY 8 I. PREAMBLE: 8 II. OVERVIEW OF THE IRB, OPRS, AND THE HUMAN SUBJECT PROTECTION PROGRAM
More informationPREP Course 24: Defining the Differences between FDA and OHRP regulations. Presented by: Hallie Kassan Dorean Flores Office of the IRB
PREP Course 24: Defining the Differences between FDA and OHRP regulations Presented by: Hallie Kassan Dorean Flores Office of the IRB CME Disclosure Statement The North Shore LIJ Health System adheres
More informationOutline of Discussion
This final rule is intended to better protect human subjects involved in research, while facilitating valuable research and reducing burden, delay, and ambiguity for investigators. These revisions are
More informationHuman Research Protection Program. Plan
Human Research Protection Program Plan Revised September 6, 2017 HRP-101 9/6/17 2 of 13 Table of Contents Scope... 3 Purpose... 3 Definitions... 3 Agent... 3 Clinical Trial... 3 Engaged in Human Research...
More informationInstitutional Review Board (IRB)
Institutional Review Board (IRB) Melissa Miklos Program Manager miklosm@upmc.edu Institutional Review Board What is the IRB? Why does the IRB exist? Where is the IRB? Who is the IRB? When do you need the
More informationHuman Research Protection Program. Plan
Human Research Protection Program Plan Dated: September 4, 2014 HRP-101 9/4/2014 2 of 14 Table of Contents Scope... 3 Purpose... 3 Definitions... 3 Agent... 3 Clinical Trial... 3 Engaged in Human Research...
More informationPrincipal Investigator s Procedure Manual for the Protection of Human Subjects (June 2004)
Downstate Medical Center State University of New York Institutional Review Board Principal Investigator s Procedure Manual for the Protection of Human Subjects (June 2004) Introduction Basic Principles
More informationEthics Committees/IRBs Today: Challenges for Efficiency and Quality
Marjorie A. Speers, Ph.D. President and CEO Ethics Committees/IRBs Today: Challenges for Efficiency and Quality Copyright 2013 AAHRPP All rights reserved Goal Clinical Research Globally Access to patients
More informationInstitutional Review Board Compliance Elizabeth City State University
Institutional Review Board Compliance Elizabeth City State University Michelle Moore, MBA Research Compliance Officer/IRB Administrator Office of Sponsored Programs, Contracts & Grants 110 McLendon Hall
More informationTitle: IRB Purpose, Principles and Responsibilities Page: 1 of 5
THE NORTH SHORE MEDICAL CENTER Institutional Review Board (IRB) POLICIES AND PROCEDURES IRB Policy Number: 001.2 Title: IRB Purpose, Principles and Responsibilities Page: 1 of 5 Written by: Laura W. Knight,
More informationExpedited Review of Human Subject Research
Expedited Review of Human Subject Research Table of Contents Eligibility for Expedited Review Expedited Review IRB Oversight of Expedited Review Research Categories Eligible for Expedited Review Review
More informationHUMAN RESEARCH PROTECTION PROGRAM PLAN
HUMAN RESEARCH PROTECTION PROGRAM PLAN HRP 101 June 2017 706-542-3199 irb@uga.edu https://research.uga.edu/hso/ Table of Contents Scope... 2 Purpose... 2 Definitions... 2 Agent... 2 Clinical Trial... 2
More informationHuman Subjects Research: IRB Resources
Research Compliance Office Human Subjects Research: IRB Resources Kristin B. Frazier HRPP Educational Specialist IRB Resources June 4, 2008 Topics Stanford Institutional Review Boards (IRB) Charge of IRB
More informationIRB-GCP and Timelines. Andrew Majewski, MSc. 1 st DOLF Meeting Washington University School of Medicine St Louis, Missouri-USA October th, 2010
IRB-GCP and Timelines Andrew Majewski, MSc. 1 st DOLF Meeting Washington University School of Medicine St Louis, Missouri-USA October 11-14 th, 2010 1 Factors that affect Timelines Finalized Protocol Finalized
More informationAPPLICATION INSTRUCTIONS INSTITUTIONAL REVIEW BOARD. Revised January 2010 Page 1
APPLICATION INSTRUCTIONS INSTITUTIONAL REVIEW BOARD Revised January 2010 Page 1 The IRB Proposal Includes: 1. All documents, other than the informed consent form, should be understandable to an informed
More informationFinal Rule Material: Secondary Research with Identifiable Information and Biospecimens
2017 Biomedical Research Alliance of New York LLC CITI Program is a division of BRANY Final Rule Material: Secondary Research with Identifiable Information and Biospecimens www.citiprogram.org Content
More informationIRB HUMAN SUBJECTS PROTECTION PROGRAM STANDARD OPERATING PROCEDURES INSTITUTIONAL REVIEW BOARD
IRB INSTITUTIONAL REVIEW BOARD HUMAN SUBJECTS PROTECTION PROGRAM STANDARD OPERATING PROCEDURES REVISED: OCTOBER, Table of Contents Page # INTRODUCTION... 1 CONTACT INFORMATION... 2 PRINCIPLES, ROLES AND
More information1 The Clinical Research Coordinator (CRC)... 1
TABLE OF CONTENTS Dedication... iii Introduction... xi 1 The Clinical Research Coordinator (CRC)... 1 Role and Responsibilities of the CRC...1 Personality and Skills... 3 Where Do CRCs Work?... 3 CRC Responsibilities...
More informationInstitutional Review Board
Institutional Review Board Overview & Minimal Risk Research Jon Mark Hirshon, MD, MPH Vice-Chairman University of Maryland Institutional Review Board May 18, 2006 Jon Mark Hirshon, MD, MPH 1 Presentation
More informationUniversity of Nevada, Las Vegas
Note: The official name of the Office for the Protection of Research Subjects (OPRS) has been changed to the Office of Research Integrity Human Subjects Research. Any reference to the Office for the Protection
More informationTitle: Review of Medical Devices Page: 1 of 5 Written by:
THE NORTH SHORE MEDICAL CENTER Institutional Review Board (IRB) POLICIES AND PROCEDURES IRB Policy Number: 031.1 Title: Review of Medical Devices Page: 1 of 5 Written by: Approved by: Laura W. Knight,
More informationUniversity of the Virgin Islands Institutional Review Board (IRB) IRB Basics for Social Science Senior Seminar (STT/STX)
University of the Virgin Islands Institutional Review Board (IRB) IRB Basics for Social Science Senior Seminar (STT/STX) Ethics and Human Subject Protections Presented by: Olusola Ewulo, M.S. Director,
More informationRegulatory Protection of Human Subjects in Research
Chapter 2 Chapter Overview The protection of human subjects in research is paramount to any research effort. Research that involves human subjects is highly regulated by federal, state, and institutional
More informationClinical Trials Management for Molecular Diagnostics. April 2016
Clinical Trials Management for Molecular Diagnostics April 2016 Clinical Operations Responsibilities Accrue samples that have proper informed consent for use Retrospective cohorts Remnant samples Prospective
More informationHuman Subjects Research Policy Update. Naomi Coll Director of Research Policy and Compliance
Human Subjects Research Policy Update Naomi Coll Director of Research Policy and Compliance Major Policy Updates 1. Activities that meet the HHS or FDA definition of human subjects research are subject
More informationResearch Data Sharing and Security: The Challenges We Face. Jon Mark Hirshon, MD, PhD, MPH Senior Vice-Chair Institutional Review Board
Research Data Sharing and Security: The Challenges We Face Jon Mark Hirshon, MD, PhD, MPH Senior Vice-Chair Institutional Review Board start us off with your involvement with the IRB and the data security/privacy
More informationRadiation - Florida Department of Health Institutional Review Board
500-26 Radiation 500-26 Radiation - Florida Department of Health Institutional Review Board Protocol title: Researcher: Application contact: For questions, concerns, to provide input, or request a consultation,
More informationEthical Issues in Clinical Trial & Development of Regulation Policy on Clinical Research
Ethical Issues in Clinical Trial & Development of Regulation Policy on Clinical Research Melody Lin, Ph.D. Deputy Director, Office for Human Research Protections Director, International Activities Department
More information1 Human Subjects Protection Training Manuel
1 Human Subjects Protection Training Manuel Human Subjects Protection: Training for Research Teams Brought to you by: Walter L. Calmbach MD MPH South Texas Ambulatory Research Network (STARNet) Dept. of
More informationHUMAN SUBJECTS RESEARCH PROTOCOLS
HUMAN SUBJECTS RESEARCH PROTOCOLS Guidelines and Application Instructions Institutional Review Board (IRB), Office of Sponsored Programs and Research (OSPR) Determine the Type of IRB Review that is Required
More informationGood Clinical Practice. Martin Rose, MD, JD February 8, 2018 ASQ
Good Clinical Practice Martin Rose, MD, JD February 8, 2018 ASQ Disclaimer The views expressed in this presentation are those of the presenter and do not necessarily represent the official position of
More informationJune 15, Adaptive Phase I Studies: The IRB Perspective Marilyn Teal, PharmD IRB Member, Schulman IRB
June 15, 2016 Adaptive Phase I Studies: The IRB Perspective Marilyn Teal, PharmD IRB Member, Schulman IRB About Schulman IRB Established in 1983 Superior audit history with FDA five consecutive audits
More informationIndex of Frequently Asked Questions
Index of Frequently Asked Questions We hope that this frequently asked questions will orient you to basic policies and procedures for IRB review and approval. Feel free to call on us as you navigate the
More informationHuman Research Protection Program Policy
Adopted: 11/2005 Revised: 03/2014 Page: 1 of 6 RIGHTS AND RESPONSIBILITIES OF PRINCIPAL INVESTIGATORS IN HUMAN SUBJECTS RESEARCH POLICY Each research study will have a Principal Investigator (PI) and may
More informationGood Clinical Practice Handbook
Division of Microbiology and Infectious Diseases Good Clinical Practice Handbook National Institute of Allergy and Infectious Diseases National Institutes of Health Department of Health and Human Services
More informationCOI IN THE MEDIA 10/8/2012 CONFLICT OF INTEREST IN HUMAN SUBJECT RESEARCH HIGH PROFILE CONFLICT OF INTEREST CASES INVOLVING HUMAN SUBJECTS
CONFLICT OF INTEREST IN HUMAN SUBJECT RESEARCH COI IN THE MEDIA Financial conflict of interest frequently appear in the media, but particularly subject to public scrutiny are those high profile adverse
More informationAdministrative Policies VMC #638.1 and Procedures Manual
Administrative Policies VMC #638.1 and Procedures Manual January 14, 2013 TO: FROM: SUBJECT: REFERENCE: VMC Employees Paul E. Lorenz Chief Executive Officer, SCVMC Research Involving Human Subjects TJC,
More information1.0 INTRODUCTION AND OVERVIEW
Table of Contents 1.0 INTRODUCTION AND OVERVIEW... 3 2.0 DEFINITIONS... 4 3.0 OVERSIGHT AND ORGANIZATION... 5 3.1 CLINICAL RESEARCH OVERSIGHT COMMITTEE (CROC)... 5 3.2 CLINICAL RESEARCH SUPPORT (CRS)...
More informationExternal IRB Review What Does it Mean for Your Institution
External IRB Review What Does it Mean for Your Institution Wesley G Byerly, Pharm.D. Associate Vice President for Research Integrity and Regulatory Affairs University of Connecticut and UCONN Health HCCA
More informationUC DAVIS OFFICE OF RESEARCH AAHRPP Preparation UC Davis Human Research Part III Investigator Manual. Cindy Gates IRB Administration
UC DAVIS OFFICE OF RESEARCH AAHRPP Preparation UC Davis Human Research Part III Investigator Manual Cindy Gates IRB Administration What is the purpose of the INVESTIGATOR MANUAL? The manual is designed
More informationHuman Research Protection Program. Investigator Manual
Human Research Protection Program Revised July 7, 2014 HRP-910 7/7/2014 2 of 10 Table of Contents What is the purpose of this manual?... 3 What is Human Research?... 3 What is the Human Research Protection
More information2 : self-directing freedom and especially moral independence 3 : a self-governing state
A Adverse Effect Adverse Event AE Amendment Approve Approve Pending Assent Assurance Authorization Autonomy Unanticipated problem or unfavorable symptom or disease occurring during a clinical study, though
More informationHCCA Compliance Institute
HCCA Compliance Institute Implementing a Clinical Research Compliance Program Kendra Dimond, Partner Epstein Becker & Green Washington, DC 202-861-0900 F. Lisa Murtha, J.D. Chief Audit and Compliance Officer
More informationInstitutional Review Board. Ensuring that the rights and welfare of participants in research are protected.
Institutional Review Board Ensuring that the rights and welfare of participants in research are protected. Michael Linke, PhD, CIP Presenters Health Science Officer, Veterans Affairs Medical Center Associate
More informationINVESTIGATOR HANDBOOK
INVESTIGATOR HANDBOOK INVESTIGATOR HANDBOOK Table of Contents MISSION... 3 FIRST TIME SUBMISSION... 3 EDUCATIONAL REQUIREMENTS... 3 PRINCIPAL INVESTIGATOR NEW STUDY SUBMISSIONS... 4 VULNERABLE POPULATIONS...
More informationInvestigator Manual HRP-103
HRP-103 Revised October 04, 2016 Table of Contents 1. Introduction... 3 A. Scope... 3 B. Purpose of this manual... 3 C. Where to get additional information and answers to questions... 3 E. Human Research
More informationResearch Involving Human Data or Specimens
Page 1 of 5 Research Involving Human Data or Specimens Introduction: The Office for Human Research Protections has issued guidance on research involving coded private information or human biological specimens.
More informationSOCIAL & BEHAVIORAL TEMPLATE WITH INSTRUCTIONS: 2.0 Background / Literature Review / Rationale for the study:
SOCIAL & BEHAVIORAL TEMPLATE WITH INSTRUCTIONS: Use this template to prepare a document for SOCIAL AND BEHAVIORAL research with the information from the following sections. Depending on the nature of what
More informationInvestigator Manual. Human Subjects Protection Program
Human Subjects Protection Program HRP-103, Revised June 1, 2015 HRP-103 06/01/2015 2 of 33 Table of Contents Scope... 3 What is the purpose of this manual?... 3 What is Human Research?... 3 What is the
More information2.0 DETERMINING ACTIVITIES THAT QUALIFY as HUMAN RESEARCH or CLINICAL INVESTIGATIONS
2.0 DETERMINING ACTIVITIES THAT QUALIFY as HUMAN RESEARCH or CLINICAL INVESTIGATIONS 2.1 OBJECTIVE To describe policies and procedures for determining the types of activities that qualifies as human research
More informationThe Nuremberg Doctor s Trial
Research fundamentals Working with the institutional review board The Nuremberg Doctor s Trial that occurred at the end of World War II is generally cited as the event that drew attention to the need for
More informationUSE OF INVESTIGATIONAL DRUGS OR BIOLOGICS IN HUMAN SUBJECTS RESEARCH
Policy P.11 Written By: B. Laurel Elder Created: June 3, 2013 Edited Replaces 10-9-2009 Version P.11.4 USE OF INVESTIGATIONAL DRUGS OR BIOLOGICS IN HUMAN SUBJECTS RESEARCH A. Procedure Contents this procedure
More information11.0 FDA-Regulated Research Research Involving Investigational Drugs and Biologics
11.0 FDA-Regulated Research The IRB evaluates the safety or efficacy of all drugs and devices used in research. Studies involving unapproved or investigational drugs or devices will be reviewed to ensure
More informationClinical trial information leaflet and consent
Informed consent 1(7) Clinical trial information leaflet and consent General You must provide sufficient information on the rights of clinical trial subjects, the purpose and nature of the trial, the methodologies
More information50 SHADES OF GRAY: WHY AND WHEN IS IRB APPROVAL REQUIRED?
50 SHADES OF GRAY: WHY AND WHEN IS IRB APPROVAL REQUIRED? Kevin L. Nellis, MS, CIP Executive Director, Human Research Protections and Quality Assurance Kathleen E. Powderly, CNM, PhD Director, John Conley
More informationHuman Research Protection Program Policy
Page 1 of 11 EMERGENCY USE OF AN INVESTIGATIONAL DRUG, BIOLOGICAL PRODUCT OR DEVICE IN HUMAN SUBJECTS RESEARCH POLICY This policy does not limit the authority of a physician to provide emergency medical
More informationINSTITUTIONAL ETHICS REVIEW COMMITTEE GLOSSARY
INSTITUTIONAL ETHICS REVIEW COMMITTEE Adverse events Amendment to the protocol Approval Assent Center for Clinical Trials Clinical research Clinical trials - Any untoward or unfavorable medical occurrence
More informationHuman Research Participant Protection Program Institutional Review Board (IRB)
Human Research Participant Protection Program Institutional Review Board (IRB) Procedure 1: Determining whether a research activity needs IRB review and approval 1. Subject All research activities that
More informationIs Your Research Involving Human Subjects Eligible for Exemption? John M. Falletta, M.D. Professor of Pediatrics Senior Chairman, DUHS IRB
Is Your Research Involving Human Subjects Eligible for Exemption? John M. Falletta, M.D. Professor of Pediatrics Senior Chairman, DUHS IRB Exemption From What??and/or By Whom? Scrutiny by anyone? SBR review?
More informationUNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE INSTITUTIONAL REVIEW BOARD CONFLICTS OF INTEREST
UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE INSTITUTIONAL REVIEW BOARD CONFLICTS OF INTEREST I. PURPOSE To document the policy and procedures used by the University of Tennessee Graduate School
More informationSITE SUBMISSION FORM (SINGLE SITE)
*We accept study submissions by email, fax or mail. 1. STUDY INFORMATION A. Sponsor: Protocol.: Study Title: B. Study Type: Drug, Biologic or Dietary Supplement (please complete section C., then proceed
More informationHuman Research Protection Program Compliance Plan
Human Research Protection Program Compliance Plan May 1, 2016 Human Research Protections Program e 1313 21 st Ave. South, Room 504, Nashville, Tennessee 37232 4315 e phone 615-322-2918 e fax 615-343-2648
More informationWhat s New in GCP? FDA Clarifies, Expands Safety Reporting Guidance
Vol. 9, No. 2, February 2013 Happy Trials to You What s New in GCP? FDA Clarifies, Expands Safety Reporting Guidance Reprinted from the Guide to Good Clinical Practice with permission of Thompson Publishing
More informationHow the Past Influenced Human Research Protection Regulations
How the Past Influenced Human Research Protection Regulations Shirley J. Hicks Director, Division of Education and Development Office for Human Research Protections U.S. Department of Health and Human
More informationMANUAL: Administrative Policy & Procedure Manual POLICY:
SJMHS Locations: St. Joseph Mercy Ann Arbor, St. Joseph Mercy Chelsea, St. Joseph Mercy Livingston, St. Mary Mercy Livonia MANUAL: Administrative Policy & Procedure Manual POLICY: Expanded access is the
More informationHuman Research Protections Program Policies and Standard Operating Procedures
Human Research Protections Program Policies and Standard Operating Procedures Version Date: April 2018 Presbyterian Healthcare Services Human Research Protections Office and Institutional Review Board
More informationCHECKLIST: Pre-review
11-5-2014 1 of 5 The purpose of this checklist is to provide support for IRB staff conducting pre-review. This checklist is to be completed by the IRB staff, signed, dated, and retained with the IRB protocol
More informationInstitutional Review Board
Institutional Review Board Policies and Procedures for the Protection of Human Subjects in Research Naval Medical Research Center Research Services Directorate Office of Research Administration Code 025,
More informationProtocol Submission Form
Protocol Submission Form 1. Administrative Information Name of Submitting Party: Street: Province/State: Postal/Zip Code: Phone: ( ) E-mail Address: Fax: ( ) Other: ( ) Date: 2. General Study Information
More informationRecruitment of Research Participants
IOWA STATE UNIVERSITY Institutional Review Board Recruitment of Research Participants Recruitment of research participants takes many forms that involve presenting potential participants with information
More informationUNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE INSTITUTIONAL REVIEW BOARD CONFLICTS OF INTEREST
UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE INSTITUTIONAL REVIEW BOARD CONFLICTS OF INTEREST I. PURPOSE To document the policy and procedures used by the University of Tennessee Graduate School
More informationUniversity of California, Irvine Human Research Protections Standard Operating Policies and Procedures
University of California, Irvine Human Research Protections Standard Operating Policies and Procedures Policy Number: 41 Title: Investigational Drugs, Agents, and Biologics Date of Last of Revision: 07/28/2006;
More informationObjectives Discuss the importance of proper data collection. Identify the types of data collected for clinical trials. List potential source documents
Data Management in Clinical Trials Introduction to the Principles and Practice of Clinical Research January 24, 2011 Diane St. Germain, RN, MS, CRNP Nurse Consultant Division of Cancer Prevention National
More information\\NAS1\George\Docs\SoCRA\CCRP communications\study guide management
Five Content Areas Percent of Scored Test Items (Range) in Each Area This table shows the percent of scored test questions that are included in each major content area. Five Content Areas Ethical Principles
More informationRESEARCH PERFORMANCE SITES AND COLLABORATIVE OFF-SITE RESEARCH
1. Overview RESEARCH PERFORMANCE SITES AND COLLABORATIVE OFF-SITE RESEARCH The ethical and regulatory requirements of The Ohio State University Human Research Protection Program (HRPP) apply to all research
More informationMARKEY CANCER CENTER STANDARD OPERATING PROCEDURES. SOP No.: MCC Type: Final
Page 1 of 11 MARKEY CANCER CENTER STANDARD OPERATING PROCEDURES SOP No.: MCC-002.03 Type: Final Title: Protocol Review and Monitoring Committee Functional Overview Approval Signature Date MCC Director
More informationCollaboration and Efficiency in IRB review of Multi-Site Research
Collaboration and Efficiency in IRB review of Multi-Site Research Human Subject Research Community Conference University of Miami Student Activities Center (SAC) September 11, 2014 Cynthia Hahn VP, Clinical
More information11.0 FDA-Regulated Research Research Involving Investigational Drugs and Biologics
11.0 FDA-Regulated Research The IRB evaluates the safety or efficacy of all drugs and devices used in research. Studies involving unapproved or investigational drugs or devices will be reviewed to ensure
More informationHuman Research Protection Program Guidance for Human Research Determination
Human Research Protection Program Guidance for Human Research Determination I.1.A The sole purpose of the Institutional Review Board (IRB), as defined in federal statutes, is the protection of human subjects
More informationUCI ADMINISTRATIVE POLICIES & PROCEDURES
UCI ADMINISTRATIVE POLICIES & PROCEDURES RESEARCH AND SPONSORED ACTIVITIES Human Stem Cell Research Oversight Program Section 484-1: Review of Human Stem Cell Activities Responsible Office: Office of Research
More informationInstitutional Review - Protection of Human Subjects
The University of Toledo The University of Toledo Digital Repository Higher Learning Commission Office of the Provost Institutional Review - Protection of Human Subjects Research, Office of Follow this
More informationStandard Operating Procedures Guidelines for Good Clinical Practice
SOP # CRSC-105 Effective Date 10-22-2013 Version # 1 Version Date 7-30-2013 Standard Operating Procedures Guidelines for Good Clinical Practice Purpose: This SOP outlines the steps required to follow FDA
More information